Physiologically-based pharmacokinetic modelling to predict intragastric rifabutin concentrations in the treatment of Helicobacter pylori infection.
Saved in:
| Title: | Physiologically-based pharmacokinetic modelling to predict intragastric rifabutin concentrations in the treatment of Helicobacter pylori infection. |
|---|---|
| Authors: | Howden CW; University of Tennessee College of Medicine, Memphis, Tennessee, USA., Shah S; University of California, San Diego, California, USA., Pendse SN; Nuventra Pharma Sciences, Durham, North Carolina, USA., Offman E; Certara Integrated Drug Development, Montreal, Quebec, Canada., Almenoff JS; RedHill Biopharma, Medical Affairs, Raleigh, North Carolina, USA., Sheldon KL; RedHill Biopharma, Medical Affairs, Raleigh, North Carolina, USA. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Jul; Vol. 58 (2), pp. 159-167. Date of Electronic Publication: 2023 Apr 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
